+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Single Photon Emission Computed Tomography Market - Global Forecast to 2030- Product Image
Single Photon Emission Computed Tomography Market - Global Forecast to 2030- Product Image
Sale

Single Photon Emission Computed Tomography Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 187 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011744
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Single Photon Emission Computed Tomography Market grew from USD 2.19 billion in 2024 to USD 2.28 billion in 2025. It is expected to continue growing at a CAGR of 3.98%, reaching USD 2.77 billion by 2030.

Single Photon Emission Computed Tomography (SPECT) has evolved into a cornerstone of molecular imaging, offering dynamic insights into physiological processes by tracing radiopharmaceutical distribution. As healthcare systems strive to improve diagnostic accuracy and personalized treatment planning, SPECT’s unique ability to visualize functional anomalies at the cellular level makes it indispensable. This executive summary distills the critical developments shaping the SPECT market, examining shifts driven by technological innovation, regulatory frameworks, and changing reimbursement landscapes. By delving into the latest trends across applications, system architectures, user segments, and geographic regions, this overview equips decision-makers with a clear understanding of how SPECT is redefining clinical pathways in cardiology, neurology, oncology, orthopedics, and pulmonology.

In recent years, advances in detector sensitivity and reconstruction algorithms have enhanced image resolution and quantitative reliability, enabling clinicians to detect pathologies earlier and tailor interventions more precisely. Concurrently, hybrid imaging modalities that integrate SPECT with CT or MRI have expanded diagnostic capabilities, offering unparalleled anatomical and functional correlation. As radiopharmaceutical pipelines grow to address emerging biomarkers, SPECT remains at the forefront of nuclear medicine, balancing cost-effectiveness with robust clinical impact. This introduction sets the stage for a comprehensive examination of market dynamics, guiding experts and leaders through the transformative forces at play.

Transformative Shifts Reshaping the SPECT Market

The SPECT landscape is undergoing transformative shifts as digital innovation converges with precision medicine. Integration of artificial intelligence and machine learning into image reconstruction workflows has accelerated the move from qualitative to quantitative interpretation, reducing scan times and standardizing diagnostic criteria. In parallel, the rise of portable and point-of-care SPECT systems has begun to decentralize nuclear imaging, making functional diagnostics more accessible in outpatient and remote settings.

Simultaneously, consolidation among healthcare providers is altering purchasing strategies, with larger networks demanding scalable, interoperable solutions that fit within enterprise-wide imaging platforms. Regulatory approvals for novel radiotracers targeting neuroreceptor pathways and tumor metabolism are set to broaden the clinical application scope, compelling manufacturers to invest in agile manufacturing and distribution capabilities. As reimbursement models pivot toward value-based care, vendors are challenged to demonstrate improved patient outcomes and cost savings through robust clinical evidence, further incentivizing collaborations between imaging specialists, pharmaceutical developers, and data scientists.

Cumulative Impact of United States Tariffs in 2025

The implementation of new U.S. tariffs in 2025 has reverberated throughout the SPECT ecosystem, affecting the cost structure of imported imaging components and radiopharmaceutical precursors. Equipment manufacturers reliant on overseas suppliers for specialized detectors and collimators have experienced increased input costs, prompting negotiations around long-term supply contracts and the exploration of domestic manufacturing partnerships. At the same time, higher tariffs on certain raw materials have driven semiconductor shortages for advanced digital detectors, requiring manufacturers to optimize component usage and seek alternative sourcing strategies.

Clinicians and procurement specialists are adjusting capital expenditure plans in response to updated tariffs, balancing the immediate impact on equipment pricing with the long-term benefits of newer, more efficient technologies. Radiopharmacies importing precursor isotopes have also reevaluated distribution routes to minimize tariff burdens, sometimes consolidating shipments or shifting toward regional production nodes. Despite near-term cost pressures, the industry’s agility in redesigning supply chains and leveraging localized manufacturing clusters suggests that tariff-related headwinds will gradually diminish as stakeholders adapt and optimize their operations.

Key Segmentation Insights Across Applications, Systems, Users, and Components

Application-driven heterogeneity defines the SPECT market, with cardiology leading adoption through detailed imaging of hypertrophic cardiomyopathy and ischemic heart disease, while neurology leverages SPECT to assess Alzheimer’s disease and Parkinson’s disease progression. In oncology, lymphoma and thyroid cancer diagnostics benefit from radiotracer specificity, and orthopedic applications such as bone fracture localization and osteoporosis monitoring continue to expand. Pulmonology relies on SPECT for functional evaluation of chronic obstructive pulmonary disease and pulmonary embolism, reinforcing the modality’s multi-disciplinary relevance.

System architecture segmentation underscores the dual pathways of hybrid SPECT systems and multi-header configurations. Hybrid platforms combining SPECT with CT provide concurrent functional and anatomical visualization, and SPECT/MRI hybrids introduce soft-tissue contrast advantages. Meanwhile, multi-header systems differentiate between fixed-angle arrangements optimized for throughput and whole-body designs suited for comprehensive clinical workflows.

End users range from independent diagnostic centers, which focus on high-volume outpatient imaging, to integrated diagnostic networks that require seamless connectivity across modalities. General hospitals leverage SPECT for broad clinical applications, whereas private hospitals emphasize specialized cardiology and oncology services. Research institutes drive innovation, with private sector laboratories pursuing commercial applications and university-associated centers focusing on translational research.

Component segmentation highlights the critical roles of hardware and software in system performance. Collimators, detectors, and gamma cameras form the technological backbone, with advances in scintillator materials and semiconductor photodetectors boosting sensitivity. On the software side, data processing algorithms refine noise reduction, image acquisition modules synchronize acquisition parameters, and advanced imaging analysis tools enable quantitative assessment and 3D visualization.

Key Regional Insights Driving Market Dynamics

Regional dynamics reveal distinct growth trajectories. In the Americas, substantial investments in healthcare infrastructure and reimbursement policies favoring value-based imaging have fueled SPECT adoption, particularly in cardiology and neurology. North American radiopharmacies benefit from regulatory frameworks that support rapid approval of novel tracers, spurring clinical research and commercial rollouts.

Europe, the Middle East, and Africa present a heterogeneous landscape where established markets in Western Europe coexist with emerging hubs in the Gulf region and Africa’s urban centers. Regulatory harmonization efforts across the EU have streamlined cross-border imaging protocols, while targeted government funding initiatives in the Middle East and Africa are accelerating capacity building for nuclear medicine facilities.

In Asia-Pacific, the confluence of rising chronic disease prevalence and expanding hospital networks underpins robust demand for functional imaging. Japan and South Korea lead in technological innovation and early adoption of hybrid systems, whereas China and India are rapidly scaling SPECT installations to meet growing diagnostic needs. Regional partnerships between equipment vendors and local distributors are essential to navigate complex regulatory environments and ensure timely service support.

Key Companies Insights and Competitive Strategies

Competitive intensity in the SPECT market is high, with established multinational corporations and specialized imaging companies vying for market share through continuous innovation and strategic collaborations. Bruker Corporation emphasizes high-resolution detector technologies, while Digirad Corporation focuses on compact, portable SPECT solutions. General Electric Company and Siemens Healthineers AG leverage extensive global service networks to support hybrid systems, complemented by robust software suites.

Koninklijke Philips N.V. integrates advanced AI-driven reconstruction into its SPECT/CT platforms, and Mediso Ltd. develops modular configurations to cater to niche research applications. MiE GmbH pushes the boundaries of quantitative imaging with semiconductor-based detectors, as MILabs BV by Rigaku Corporation pioneers ultra-high resolution systems for preclinical studies. Novartis AG’s investment in radiotracer development underscores the synergy between pharmaceutical and imaging enterprises, while Spectrum Dynamics Medical Inc. by Biosensors International Group offers streamlined workflows for high-throughput diagnostic centers. The Bracco Group completes the competitive landscape by supplying a range of radiopharmaceuticals and contrast agents tailored for SPECT procedures.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize several strategic imperatives to capture value in the evolving SPECT environment. First, accelerating integration of artificial intelligence into image acquisition and analysis workflows will be essential to differentiate offerings and improve diagnostic consistency. Second, forging cross-industry partnerships with radiopharmaceutical developers and academic research centers can drive co-innovation of novel tracers and targeted imaging protocols.

Third, strengthening supply chain resilience by diversifying component sourcing and investing in regional manufacturing capabilities will mitigate the impact of future tariff fluctuations. Fourth, expanding service models to include subscription-based maintenance and performance optimization contracts will align vendor incentives with clinical outcomes, fostering long-term customer loyalty. Fifth, customizing product portfolios for emerging markets-through modular system designs and flexible pricing schemes-will unlock new growth opportunities in Asia-Pacific and EMEA regions.

By embedding these recommendations into their strategic roadmaps, imaging vendors and healthcare providers can not only navigate current headwinds but also position themselves at the forefront of a market that increasingly demands precision, efficiency, and demonstrable value.

Conclusion: Charting the Future of SPECT Imaging

The SPECT market stands at a pivotal juncture, where the convergence of technological breakthroughs, evolving clinical paradigms, and shifting economic forces will define the next era of functional imaging. Stakeholders who embrace digital transformation, cultivate collaborative innovation, and remain agile in their operational strategies will secure competitive advantage. As application domains expand and end-user expectations intensify, the ability to deliver high-resolution, quantitative SPECT insights with efficient service support will distinguish market leaders from followers.

Ultimately, success in this landscape hinges on a deep understanding of end-user workflows, regulatory complexities, and emerging radiotracer opportunities. By sustaining a relentless focus on clinical value and patient outcomes, the SPECT community can continue to enhance diagnostic confidence and drive personalized care pathways across cardiology, neurology, oncology, orthopedics, and pulmonology.

Market Segmentation & Coverage

This research report categorizes the Single Photon Emission Computed Tomography Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Cardiology
    • Hypertrophic Cardiomyopathy
    • Ischemic Heart Disease
  • Neurology
    • Alzheimer's Disease
    • Parkinson's Disease
  • Oncology
    • Lymphoma
    • Thyroid Cancer
  • Orthopedics
    • Bone Fractures
    • Osteoporosis
  • Pulmonology
    • Chronic Obstructive Pulmonary Disease
    • Pulmonary Embolism
  • Hybrid SPECT Systems
    • SPECT/CT
    • SPECT/MRI
  • Multi-Header SPECT Systems
    • Fixed-Angle
    • Whole-Body
  • Diagnostic Centers
    • Independent Diagnostic Centers
    • Integrated Diagnostic Networks
  • Hospitals
    • General Hospitals
    • Private Hospitals
  • Research Institutes
    • Private Sector
    • University-Associated
  • Hardware
    • Collimators
    • Detectors
    • Gamma Cameras
  • Software
    • Data Processing
    • Image Acquisition
    • Imaging Analysis

This research report categorizes the Single Photon Emission Computed Tomography Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Single Photon Emission Computed Tomography Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Bruker Corporation
  • Digirad Corporation
  • General Electric Company
  • Koninklijke Philips N.V.
  • Mediso Ltd.
  • MiE GmbH
  • MILabs BV by Rigaku Corporation
  • Novartis AG
  • Siemens Healthineers AG
  • Spectrum Dynamics Medical Inc. by Biosensors International Group
  • The Bracco Group

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Single Photon Emission Computed Tomography Market, by Application
8.1. Introduction
8.2. Cardiology
8.2.1. Hypertrophic Cardiomyopathy
8.2.2. Ischemic Heart Disease
8.3. Neurology
8.3.1. Alzheimer's Disease
8.3.2. Parkinson's Disease
8.4. Oncology
8.4.1. Lymphoma
8.4.2. Thyroid Cancer
8.5. Orthopedics
8.5.1. Bone Fractures
8.5.2. Osteoporosis
8.6. Pulmonology
8.6.1. Chronic Obstructive Pulmonary Disease
8.6.2. Pulmonary Embolism
9. Single Photon Emission Computed Tomography Market, by Type
9.1. Introduction
9.2. Hybrid SPECT Systems
9.2.1. SPECT/CT
9.2.2. SPECT/MRI
9.3. Multi-Header SPECT Systems
9.3.1. Fixed-Angle
9.3.2. Whole-Body
10. Single Photon Emission Computed Tomography Market, by End User
10.1. Introduction
10.2. Diagnostic Centers
10.2.1. Independent Diagnostic Centers
10.2.2. Integrated Diagnostic Networks
10.3. Hospitals
10.3.1. General Hospitals
10.3.2. Private Hospitals
10.4. Research Institutes
10.4.1. Private Sector
10.4.2. University-Associated
11. Single Photon Emission Computed Tomography Market, by Component
11.1. Introduction
11.2. Hardware
11.2.1. Collimators
11.2.2. Detectors
11.2.3. Gamma Cameras
11.3. Software
11.3.1. Data Processing
11.3.2. Image Acquisition
11.3.3. Imaging Analysis
12. Americas Single Photon Emission Computed Tomography Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Single Photon Emission Computed Tomography Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Single Photon Emission Computed Tomography Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Bruker Corporation
15.3.2. Digirad Corporation
15.3.3. General Electric Company
15.3.4. Koninklijke Philips N.V.
15.3.5. Mediso Ltd.
15.3.6. MiE GmbH
15.3.7. MILabs BV by Rigaku Corporation
15.3.8. Novartis AG
15.3.9. Siemens Healthineers AG
15.3.10. Spectrum Dynamics Medical Inc. by Biosensors International Group
15.3.11. The Bracco Group
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET MULTI-CURRENCY
FIGURE 2. SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET MULTI-LANGUAGE
FIGURE 3. SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HYPERTROPHIC CARDIOMYOPATHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ISCHEMIC HEART DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY THYROID CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY BONE FRACTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PULMONOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PULMONOLOGY, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HYBRID SPECT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SPECT/CT, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SPECT/MRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HYBRID SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI-HEADER SPECT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY FIXED-ANGLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY WHOLE-BODY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI-HEADER SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY INDEPENDENT DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY INTEGRATED DIAGNOSTIC NETWORKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PRIVATE SECTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY UNIVERSITY-ASSOCIATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COLLIMATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DETECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GAMMA CAMERAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DATA PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY IMAGE ACQUISITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY IMAGING ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PULMONOLOGY, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HYBRID SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI-HEADER SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PULMONOLOGY, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HYBRID SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI-HEADER SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PULMONOLOGY, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HYBRID SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI-HEADER SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 109. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 111. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 112. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 113. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 114. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PULMONOLOGY, 2018-2030 (USD MILLION)
TABLE 115. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HYBRID SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 117. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI-HEADER SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 118. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 120. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 121. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 122. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 123. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 124. CANADA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 125. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 127. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 128. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 129. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 130. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PULMONOLOGY, 2018-2030 (USD MILLION)
TABLE 131. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HYBRID SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 133. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI-HEADER SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 134. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 136. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 137. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 138. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 139. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 140. MEXICO SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 141. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PULMONOLOGY, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HYBRID SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI-HEADER SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 157. UNITED STATES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 158. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 160. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 162. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PULMONOLOGY, 2018-2030 (USD MILLION)
TABLE 164. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HYBRID SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI-HEADER SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 175. AUSTRALIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. AUSTRALIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 177. AUSTRALIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 178. AUSTRALIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 179. AUSTRALIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 180. AUSTRALIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PULMONOLOGY, 2018-2030 (USD MILLION)
TABLE 181. AUSTRALIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 182. AUSTRALIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HYBRID SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 183. AUSTRALIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI-HEADER SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 184. AUSTRALIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. AUSTRALIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 186. AUSTRALIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 187. AUSTRALIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 188. AUSTRALIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 191. CHINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. CHINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 193. CHINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 194. CHINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 195. CHINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 196. CHINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PULMONOLOGY, 2018-2030 (USD MILLION)
TABLE 197. CHINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 198. CHINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HYBRID SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 199. CHINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI-HEADER SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 200. CHINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. CHINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 202. CHINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 203. CHINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 204. CHINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 205. CHINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 206. CHINA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 207. INDIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. INDIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 209. INDIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 210. INDIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 211. INDIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 212. INDIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PULMONOLOGY, 2018-2030 (USD MILLION)
TABLE 213. INDIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 214. INDIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HYBRID SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 215. INDIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI-HEADER SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 216. INDIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. INDIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 218. INDIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 219. INDIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 220. INDIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 221. INDIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 222. INDIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 223. INDONESIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. INDONESIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 225. INDONESIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 226. INDONESIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 227. INDONESIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 228. INDONESIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PULMONOLOGY, 2018-2030 (USD MILLION)
TABLE 229. INDONESIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 230. INDONESIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HYBRID SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 231. INDONESIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI-HEADER SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 232. INDONESIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. INDONESIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 234. INDONESIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 235. INDONESIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 236. INDONESIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 237. INDONESIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 239. JAPAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. JAPAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 241. JAPAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 242. JAPAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 243. JAPAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 244. JAPAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PULMONOLOGY, 2018-2030 (USD MILLION)
TABLE 245. JAPAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 246. JAPAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HYBRID SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 247. JAPAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI-HEADER SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 248. JAPAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. JAPAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 250. JAPAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 251. JAPAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 252. JAPAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 253. JAPAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 254. JAPAN SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 255. MALAYSIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PULMONOLOGY, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 262. MALAYSIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HYBRID SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 263. MALAYSIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI-HEADER SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 264. MALAYSIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. MALAYSIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 266. MALAYSIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 267. MALAYSIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 268. MALAYSIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 269. MALAYSIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 270. MALAYSIA SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 271. PHILIPPINES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. PHILIPPINES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 273. PHILIPPINES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 274. PHILIPPINES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 275. PHILIPPINES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 276. PHILIPPINES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY PULMONOLOGY, 2018-2030 (USD MILLION)
TABLE 277. PHILIPPINES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 278. PHILIPPINES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY HYBRID SPECT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 279. PHILIPPINES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY MULTI-HEADER SPECT SYSTEMS,

Companies Mentioned

  • Bruker Corporation
  • Digirad Corporation
  • General Electric Company
  • Koninklijke Philips N.V.
  • Mediso Ltd.
  • MiE GmbH
  • MILabs BV by Rigaku Corporation
  • Novartis AG
  • Siemens Healthineers AG
  • Spectrum Dynamics Medical Inc. by Biosensors International Group
  • The Bracco Group

Methodology

Loading
LOADING...

Related Topics

Related Reports

Single-Photon Emission Computed Tomography (SPECT) Market Report 2025 - Product Image

Single-Photon Emission Computed Tomography (SPECT) Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Single-photon Emission Computed Tomography Market Size, Share & Trends Analysis Report By Product (Stand-alone SPECT Systems, Hybrid SPECT Systems), By Application (Cardiology, Oncology), By End Use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Single-photon Emission Computed Tomography Market Size, Share & Trends Analysis Report By Product (Stand-alone SPECT Systems, Hybrid SPECT Systems), By Application (Cardiology, Oncology), By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 180 Pages
  • Global
From
Single Photon Emission Computed Tomography (SPECT) - Global Strategic Business Report - Product Image

Single Photon Emission Computed Tomography (SPECT) - Global Strategic Business Report

  • Report
  • 469 Pages
  • Global
From
Single Photon Emission Computed Tomography (SPECT) Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Single Photon Emission Computed Tomography (SPECT) Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 85 Pages
  • Global
From
Positron Emission Tomography (PET) Nuclear Medicine Market 2024 - Product Image

Positron Emission Tomography (PET) Nuclear Medicine Market 2024

  • Report
  • 175 Pages
  • Global
From

About the Spect Imaging Market

Spect Imaging is a type of medical imaging that uses single photon emission computed tomography (SPECT) to create 3D images of the body. It is used to diagnose and monitor a variety of medical conditions, including heart disease, cancer, and neurological disorders. SPECT imaging is a non-invasive procedure that uses a radioactive tracer to measure the activity of organs and tissues. The tracer is injected into the patient's bloodstream and then detected by a gamma camera, which produces a 3D image of the body. Spect Imaging is a growing market in the medical imaging industry. It is used to diagnose and monitor a variety of medical conditions, and its non-invasive nature makes it a popular choice for many patients. It is also used in research and clinical trials to better understand the progression of diseases. Some companies in the Spect Imaging market include GE Healthcare, Siemens Healthineers, Philips Healthcare, and Toshiba Medical Systems. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.